J M Walenga Selected Research

J M Walenga Research Topics

12	Thrombocytopenia (Thrombopenia) 04/2015 - 04/2000
8	Thrombosis (Thrombus) 12/2012 - 04/2000
3	Hemorrhage 04/2001 - 08/2000
2	Acute Coronary Syndrome 04/2001 - 08/2000
2	Inflammation (Inflammations) 02/2001 - 04/2000
1	Rupture 04/2001
1	Alopecia (Baldness) 04/2001
1	Osteoporosis 04/2001
1	Burns 02/2001
1	Venous Thromboembolism 01/2001
1	Atherosclerosis 11/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2000
1	Myocardial Infarction 08/2000
1	Unstable Angina 08/2000
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2000
1	Disseminated Intravascular Coagulation 03/2000
1	Wounds and Injuries (Trauma) 03/2000

15	Heparin (Liquaemin)FDA LinkGeneric 04/2015 - 04/2000
4	AnticoagulantsIBA 04/2015 - 08/2000
4	AntibodiesIBA 04/2015 - 05/2000
3	AntithrombinsIBA 01/2005 - 03/2000
3	Thrombin FDA Link 02/2001 - 04/2000
2	Platelet Factor 4IBA 09/2009 - 05/2000
2	Thromboplastin (Tissue Factor)IBA 04/2001 - 04/2000
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2000 - 08/2000
1	Fibrinogen (Factor I)FDA Link 12/2012
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2012
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2012
1	apixabanIBA 06/2010
1	RivaroxabanIBA 06/2010
1	Dabigatran FDA Link 06/2010
1	Serotonin (5 Hydroxytryptamine)IBA 10/2005
1	ecarinIBA 01/2005
1	lepirudin (Refludan)FDA Link 01/2005
1	Ribosomal DNA (rDNA)IBA 01/2005
1	HirudinsIBA 01/2005
1	Platelet Membrane GlycoproteinsIBA 04/2001
1	Platelet Membrane Glycoprotein IIbIBA 04/2001
1	argatroban (MPQA)FDA Link 04/2001
1	Antithrombin IIIIBA 01/2001
1	Abciximab (ReoPro)FDA Link 12/2000
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2000
1	Complement System Proteins (Complement)IBA 11/2000
1	ThienopyridinesIBA 08/2000
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2000
1	Glycoproteins (Glycoprotein)IBA 08/2000
1	Sodium Citrate FDA LinkGeneric 04/2000
1	P-SelectinIBA 04/2000
1	Proteins (Proteins, Gene)FDA Link 04/2000
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2000
1	Peptide Hydrolases (Proteases)FDA Link 04/2000

2	Therapeutics 04/2001 - 08/2000
1	Surgical Amputation (Amputations) 04/2001
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 03/2001
1	Length of Stay 02/2001
1	Combination Drug Therapy (Combination Chemotherapy) 08/2000